Norsk forening for medisinsk mikrobiologi


Publikasjoner i 2000

  1. Andersen, B. M. and M. Rasch. 2000.Hospital-acquired infections in Norwegian long-term-care institutions. Athree-year survey of hospital-acquired infections and antibiotic treatment innursing/residential homes,including 4500 residents in Oslo. J.Hosp.Infect.46:288-296.

  2. Andersen, B. M., S. H. Ringertz, T. P. Gullord, W. Hermansen, M. Lelek,B. I. Norman, M. T. Nystad, K. A. Rod, R. T. Roed, I. J. Smidesang, N. Solheim,S. Tandberg, R. Halsnes, and H. M. Wenche. 2000. A three-year survey ofnosocomial and community-acquired infections, antibiotic treatment andre-hospitalization in a Norwegian health region. J.Hosp.Infect. 44:214-223.

  3. Ankarloo, J., D. A. Caugant, B. M. Hansen, A. Berg, A. B. Kolstø, and A. Løvgren. 2000. Genome stability of Bacillus thuringiensis subsp. israelensis isolates. Curr.Microbiol.  40:51-56.

  4. Aukrust, P., S. Bjørnsen, B. Lunden, K.Otterdal, E. C. Ng, W. Ameln, T. Ueland, F. Müller, N. O. Solum, F. Brosstad,and S. S. Frøland.2000. Persistently elevatedlevels of von Willebrand factor antigen in HIV infection. Downregulation duringhighly active antiretroviral therapy. Thromb.Haemost. 84:183-187.

  5. Aukrust, P., F. Müller, T.Ueland, A. M. Svardal, R. K. Berge, and S. S. Frøland.2000. Decreas ed vitamin Alevels in common variable immunodeficiency: vitamin A supplementation in vivoenhances immunoglobulin production and downregulates inflammatory responses.Eur.J.Clin.Invest 30:252-259.

  6. Bendiksen, S., M. Van Ghelue, O. P. Rekvig, T.Gutteberg, H. J. Haga, and U. Moens.2000. A longitudinal study ofhuman cytomegalovirus serology and viruria fails to detect active viralinfection in 20 systemic lupus erythematosus patients. Lupus 9:120-126.

  7. Berdal, B. P., R. Mehl, H. Haaheim, M. Loksa,R. Grunow, J. Burans, C. Morgan, and H. Meyer. 2000. Field detection ofFrancisella tularensis. Scand.J.Infect.Dis. 32:287-291.

  8. Borgen K., G.S. Simonsen, A. Sundsfjord, Y. Wasteson, Ø. Olsvik, and H.Kruse. 2000. Continuing high prevalence of VanA-type vancomycin-resistantenterococci on Norwegian poultry farms three years after avoparcin was banned.J.Appl.Microbiol. 89:478-485.

  9. Bruu, A. L., R. Hjetland, E. Holter, L.Mortensen, O. Natas, W. Petterson, A. G. Skar, T. Skarpaas, T. Tjade, and B.Åsjø. 2000.Evaluation of 12 commercialtests for detection of Epstein-Barr virus- specific and heterophile antibodies.Clin.Diagn.Lab Immunol. 7:451-456.

  10. Dahl, K. H., E. W. Lundblad,T. P. Røkenes, Ø. Olsvik, and A. Sundsfjord.2000. Genetic linkage of thevanB2 gene cluster to Tn5382 in vancomycin- resistant enterococci andcharacterization of two novel insertion sequences. Microbiology 146 ( Pt6):1469-1479.

  11. Dyrhol-Riise, A. M., A. B.Brantsæter, O. Dunlop, K. Baklien, A. G. Skar, B. Åsjø, J. N. Bruun, and B. I.Røsok.2000. Early changes inperipheral blood T cell subsets induced by antiretroviral treatment of humanimmunodeficiency virus-1 positive individuals. Scand.J.Immunol. 51:195-201.

  12. Eskild, A., S. Jeansson,J. A. Hagen, P. A. Jenum, and A. Skrondal.2000. Herpes simplex virustype-2 antibodies in pregnant women: the impact of the stage of pregnancy. Epidemiol.Infect. 125:685-692.

  13. Fiane, A. E., T. E. Mollnes, and M. Degre.2000. Pig endogenous retrovirus--a threat to clinical xenotransplantation? APMIS 108:241-250.

  14. Frøholm, L. O., A. B. Kolstø, J. M. Berner, and D. A. Caugant. 2000. Genomic rearrangements in neisseria meningitidis strains of the ET-5 complex. Curr.Microbiol. 40:372-379.

  15. Grewal, H. M., K. T. Hemming, H. Vetvik, C. en,H. K. Gjessing, H. Sommerfelt, and B. Haneberg.2000. Measurement of specificIgA in faecal extracts and intestinal lavage fluid for monitoring of mucosalimmune responses. J.Immunol.Methods 239:53-62.

  16. Harthug, S., A. Digranes, O. Hope, B. E.Kristiansen, A. G. Allum, and N. Langeland. 2000. Vancomycin resistance emergingin a clonal outbreak caused by ampicillin-resistant Enterococcus faecium.Clin.Microbiol.Infect. 6:19-28.

  17. Hartmann, A., C. E. Halvorsen, T. Jenssen, A.Bjørneklett, I. B. Brekke, S. J. Bakke, H. Hirschberg, T. Tønjum, and P.Gaustad.2000. Intracerebral abscesscaused by Nocardia otitidiscaviarum in a renal transplant patient--cured byevacuation plus antibiotic therapy. Nephron 86:79-83.

  18. Haugeberg, G., R. Bie, and S.A. Nordbø.2000. Chlamydia pneumoniae notdetected in temporal artery biopsies from patients with temporal arteritis.Scand.J.Rheumatol. 29:127-128.

  19. Haugen, G., P. A. Jenum, D. Scheie, S. Sund,and B. Stray-Pedersen. 2000. Prenatal diagnosis of tracheal obstruction:possible association with maternal pertussis infection. UltrasoundObstet.Gynecol. 15:69-73.

  20. Heir, E., B. A. Lindstedt, T. Vardund, Y. Wasteson, and G. Kapperud. 2000. Genomic fingerprinting of shigatoxin-producing Escherichia coli (STEC) strains: comparison of pulsed-field gel electrophoresis (PFGE) and fluorescent amplified-fragment-length polymorphism (FAFLP). Epidemiol.Infect. 125:537-548.

  21. Heldal, E., H. Docker, D. A. Caugant, and A. Tverdal. 2000. Pulmonary tuberculosis in Norwegian patients. The role of reactivation, re-infection and primary infection assessed by previous mass screening data and restriction fragment length polymorphism analysis. Int.J.Tuberc.Lung Dis. 4:300-307.

  22. Helgason, E., D. A. Caugant, I. Olsen, and A. B. Kolstø. 2000. Genetic structure of population of Bacillus cereus and B. thuringiensis isolates associated with periodontitis and other human infections. J.Clin.Microbiol. 38:1615-1622.

  23. Helgason, E., O. A. Okstad, D. A. Caugant, H. A. Johansen, A. Fouet, M. Mock, I. Hegna, and Kolstø. 2000. Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis--one species on the basis of genetic evidence. Appl.Environ.Microbiol. 66:2627-2630.

  24. Henriksen, T. H., A. Lia, R. Schøyen, T.Thoresen, and A. Berstad. 2000. Assessment of optimal atmospheric conditions forgrowth of Helicobacter pylori. Eur.J.Clin.Microbiol.Infect.Dis. 19:718-720.

  25. Hetland, G., N. Ohno, I. S. Aaberge, and M.Løvik. 2000. Protective effect of beta-glucan against systemic Streptococcuspneumoniae infection in mice. FEMS Immunol.Med.Microbiol. 27:111-116.

  26. Hetland, G., A. B. Samuelsen, M. Løvik, B. S.Paulsen, I. S. Aaberge, E. C. Groeng, and T. E. Michaelsen.2000. Protectiveeffect of Plantago major L. Pectin polysaccharide against systemic Streptococcuspneumoniae infection in mice. Scand.J.Immunol. 52:348-355.

  27. Hilse, R., J. Stoevesandt, D. A. Caugant, H. Claus, M. Frosch, and U. Vogel. 2000. Distribution of the meningococcal insertion sequence IS1301 in clonal lineages of Neisseria meningitidis. Epidemiol.Infect. 124:337-340.

  28. Jacobsen, M.B., P. Aukrust, E.Kittang, F. Müller, T. Ueland, J. Bratlie, V. Bjerkeli, and M.H. Vatn. 2000.Relation between food provocation and systemic immune activation in patients with food intolerance. Lancet 356(9227):400-401.

  29. Jelfs, J., R. Munro, E. Wedege, and D. A. Caugant. 2000. Sequence variation in the porA gene of a clone of Neisseria meningitidis during epidemic spread. Clin.Diagn.Lab Immunol. 7:390-395.

  30. Jelfs, J., R. Munro, F. E. Ashto, and D. A. Caugant. 2000. Genetic characterization of a new variant within the ET-37 complex of Neisseria meningitidis associated with outbreaks in various parts of the world. Epidemiol.Infect. 125:285-298.

  31. Jensenius, M., E. A. Høiby, D. Berild, M. Stiris, and S. H. Ringertz.2000. Difficulties in diagnosing Brucella spondylitis. Scand.J.Infect.Dis.32:425-426.

  32. Johannessen, G. S., G. Kapperud, and H. Kruse. 2000. Occurrence of pathogenic Yersinia enterocolitica in Norwegian pork products determined by a PCR method and a traditional culturing method. Int.J.Food Microbiol. 54:75-80.

  33. Kuebler,W.M., J. Borgees, A. Sckell, G.E.H. Kuhnle, and K. Bergh. 2000. Role ofL-Selectin in Leukocyte Sequestration in Lung Capillaries in a Rabbit Model ofEndoxemia. Am. J. Resp. Crit. Care Med. 161: 36-43.

  34. Leegaard, T. M., D. A. Caugant, L. O. Frøholm, and E. A. Høiby. 2000. Apparent differences in antimicrobial susceptibility as a consequence of national guidelines. Clin.Microbiol.Infect. 6:290-293.

  35. Leegaard, T. M., D. A. Caugnat, L. O. Frøholm,E. A. Høiby, and J. Lassen. 2000. Emerging antibiotic resistance in Salmonella typhimurium in Norway. Epidemiol.Infect. 125:473-480.

  36. Lindstedt, B. A., E. Heir, T. Vardund, and G. Kapperud. 2000. A variation of the amplified-fragment length polymorphism (AFLP) technique using three restriction endonucleases, and assessment of the enzyme combination BglII-MfeI for AFLP analysis of Salmonella enterica subsp. enterica isolates. FEMS Microbiol.Lett. 189:19-24.

  37. Lindstedt, B. A., E. Heir, T. Vardund, and G. Kapperud. 2000. Fluorescent amplified-fragment length polymorphism genotyping of Salmonella enterica subsp. enterica serovars and comparison with pulsed- field gel electrophoresis typing. J.Clin.Microbiol. 38:1623-1627.

  38. Lindstedt, B. A., E. Heir, T. Vardund, K. K.Melby, and G. Kapperud. 2000. Comparative fingerprinting analysis ofCampylobacter jejuni subsp. jejuni strains by amplified-fragment lengthpolymorphism genotyping. J.Clin.Microbiol. 38:3379-3387.

  39. Medhus, A. W., J. Bondi, P. Gaustad, and E.Husebye. 2000. Low-dose intravenous erythromycin: effects on postprandial andfasting motility of the small bowel. Aliment.Pharmacol.Ther. 14:233-240.

  40. Melby, K. K., J. G. Svendby, T. Eggebø, L. A.Holmen, B. M. Andersen, L. Lind, E. Sjøgren, and B. Kaijser.2000. Outbreak ofCampylobacter infection in a subartic community. Eur.J.Clin.Microbiol.Infect.Dis. 19:542-544.

  41. Müller, F., A. M. Svardal, I. Nordøy, R. K.Berge, P. Aukrust, and S. S. Frøland.2000. Virological andimmunological effects of antioxidant treatment in patients with HIV infection.Eur.J.Clin.Invest 30:905-914.

  42. Mustafa, T., S. Phyu, R. Nilsen, R. Jonsson,and G. Bjune. 2000. In situ expression of cytokines and cellular phenotypes inthe lungs of mice with slowly progressive primary tuberculosis. Scand.J.Immunol.51:548-556.

  43. Nilsen, A. and H. Myrmel.2000. Changingtrends in genital herpes simplex virus infection in Bergen, Norway. ActaObstet.Gynecol.Scand. 79:693-696.

  44. Nordbø, S. A., S. Krokstad, P. Winge, F. E.Skjeldestad, and A. B. Dalen.2000. Prevalence of GB virus C(also called hepatitis G virus) markers in Norwegian blood donors.J.Clin.Microbiol. 38:2584-2590.

  45. Nordbø, S. A., K. Lund, and F. E. Skjeldestad.2000.Retesting and follow-up of first-catch urines from men yield variable resultswith three Chlamydia trachomatis nucleic acid amplification tests. APMIS108:725-728.

  46. Nordøy, I., F. Müller, K. P.Nordal, H. Rollag, P. Aukrust, and S. S. Frøland.2000. Chemokines and solubleadhesion molecules in renal transplant recipients with cytomegalovirusinfection. Clin.Exp.Immunol. 120:333-337.

  47. Nordøy, I., F. Müller, K. P.Nordal, H. Rollag, E. Lien, P. Aukrust, and S. S. Frøland.2000. The role ofthe tumor necrosis factor system and interleukin-10 during cytomegalovirusinfection in renal transplant recipients. J.Infect.Dis. 181:51-57.

  48. Nossum, V., A.Hjelde, Kaltenborn, A.O. Brubakk, and K. Bergh. 2000. Lack of anti-Cramonoclonal antibody on endothelial injury by gas bubbles in the rabbit. Underseaand Hyperbaric Medicine 27(1): 27-35.

  49. Phyu, S., A. Tadesse, T. Mustafa, S. Tadesse,R. Jonsson, and G. Bjune. 2000. Diversity of lung and spleen immune responses inmice with s lowly progressive primary tuberculosis. Scand.J.Immunol.51:147-154.

  50. Ringertz, S. H., E. A. Høiby, M. Jensenius, J. Maehlen, D. A. Caugant, A. Myklebust, and K. Fossum. 2000. Injectional anthrax in a heroin skin-popper. Lancet 356:1574-1575.

  51. Rokbi, B., G. Renauld-Mongenie, M. Mignon, B. Danve, D. Poncet, C. Chabanel, D. A. Caugant, and M. J. Quentin-Millet. 2000. Allelic diversity of the two transferrin binding protein B gene isotypes among a collection of Neisseria meningitidis strains representative of serogroup B disease: implication for the composition of a recombinant TbpB-based vaccine. Infect.Immun. 68:4938-4947.

  52. Rørvik, L. M., B. Aase, T. Alvestad, and D. A. Caugant. 2000. Molecular epidemiological survey of Listeria monocytogenes in seafoods and seafood-processing plants. Appl.Environ.Microbiol. 66:4779-4784.

  53. Sagedal, S., K. P. Nordal, A. Hartmann, M.Degre, E. Holter, A. Foss, K. Osnes, T. Leivestad, P. Fauchald, and H. Rollag.2000. A prospective study of the natural course of cytomegalovirus infection anddisease in renal allograft recipients. Transplantation 70:1166-1174.

  54. Sandven, P. 2000. Epidemiology of candidemia. Rev.Iberoam.Micol.17:73-81.

  55. Satas, S., N. O. Hoem, K. Melby, H. Porter, C.G. Lindgren, A. Whitelaw, and M. Thoresen. 2000. Influence of mild hypothermiaafter hypoxia-ischemia on the pharmacokinetics of gentamicin in newborn pigs.Biol.Neonate 77:50-57.

  56. Simonsen, G. S., M. R. Myhre, K. H. Dahl, O.Olsvik, and A. Sundsfjord. 2000. Typeability of Tn1546-like elements invancomycin-resistant enterococci using long-range PCRs and specific analysis ofpolymorphic regions. Microb.Drug Resist.6:49-57.

  57. Sindre, H., G. Haraldsen, S. Beck, K. Hestdal,D. Kvale, P. Brandtzaeg, M. Degre, and H. Rollag.2000. Human intestinalendothelium shows high susceptibility to cytomegalovirus and altered expressionof adhesion molecules after infection. Scand.J.Immunol. 51:354-360.

  58. Sindre, H., H. Rollag, M. Degre, and K.Hestdal.2000. Human cytomegalovirusinduced inhibition of hematopoietic cell line growth is initiated by eventstaking place before translation of viral gene products. Arch.Virol.145:99-111.

  59. Sindre, H., H. Rollag, M. K. Olafsen, M. Degre,and K. Hestdal. 2000. Human cytomegalovirus induces apoptosis in thehematopoietic cell line MO7e.APMIS 108:223-230.

  60. Skogen, V., P. A. Jenum, E. Danilov, V. N.Korolev, D. S. Halvorsen, and H. Sjursen.2000. Immunity to diphtheriaamong children in Northern Nor way and North- Western Russia.Vaccine19:197-203.

  61. Solheim, B. G., H. Rollag, J. L. Svennevig, O.Arafa, E. Fosse, and U. Bergerud.2000. Viral safety ofsolvent/detergent-treated plasma. Transfusion 40:84-90.

  62. Sow, A. I., D. A. Caugant, M. F. Cisse, E. A. Høiby, and A. Samb. 2000. Molecular characteristics and susceptibility to antibiotics of serogroup A Neisseria meningitidis strains isolated in Senegal in 1999. Scand.J.Infect.Dis. 32:185-187.

  63. Stigum, H., P. Magnus, H. H. Samdal, and E.Nord. 2000. Human T-cell lymphotropic virus testing of blood donors in Norway: acost-effect model. Int.J.Epidemiol. 29:1076-1084.

  64. Stylianou, E., P. Aukrust, K. Bendtzen, F.Müller, and S. S. Frøland. 2000. Interferons and interferon (IFN)-inducibleprotein 10 during highly active anti-retroviral therapy (HAART)-possibleimmunosuppressive role of IFN-alpha in HIV infection. Clin.Exp.Immunol.119:479-485.

  65. Stylianou, E., P. Aukrust, I. Nordøy, F.Müller, and S. S. Frøland. 2000. Enhancement of lymphocyte proliferation inducedby interleukin-12 and anti-interleukin-10 in HIV-infected patients during highlyactive antiretroviral therapy. APMIS 108:601-607.

  66. Tannæs, T., H. J. Grav, and G. Bukholm. 2000.Lipid profiles of Helicobacter pylori colony variants.APMIS 108:349-356.

  67. Tollersrud, T., K. Kenny, D. A. Caugant, and A. Lund. 2000. Characterisation of isolates of Staphylococcus aureus from acute, chronic and subclinical mastitis in cows in Norway. APMIS 108:565-572.

  68. Vogel, U., H. Claus, M. Frosch, and D. A. Caugant. 2000. Molecular basis for distinction of the ET-15 clone within the ET-37 complex of Neisseria meningitidis. J.Clin.Microbiol. 38:941-942.

  69. Voltersvik, P., A. Halstensen, N. Langeland, A.Digranes, L. E. Peterson, T. Rolstad, and C. O. Solberg.2000. Eradication ofnon-typhoid salmonellae in acute enteritis after therapy with ofloxacin for 5 or10 days. J.Antimicrob.Chemother. 46:457-459.

  70. Warris, A., F. Wesenberg, P. Gaustad, P. E.Verweij, and T. G. Abrahamsen. 2000. Acremonium strictum fungaemiain apaediatric patient with acute leukaemia. Scand.J.Infect.Dis.32:442-444.

  71. Witzø,E.,L.Persen,K. Løseth, P. Benum, and K. Bergh. 2000. Cancellous bone as an antibioticcarrier. Acta Orthopaed. Scand. 71: 80-84.

  72. Ødegård,A., J. Lundbom, H.O. Myhre,S. Hatlinghus,K. Bergh, A. Waage,K.S. Bjerve, T.E. Mollnes, Aadahl, T.A. Lie, and V. Videm. 2000. The inflammatory response following treatment of abdominal aorticaneurysms: a comparoison between open surgery and endovascular repair. Eur. J.Vasc. Surg. 19: 536-44.